|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 172 Tissue Microarray - LS-SCA172This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA172 |
| Product Name: | General Cancer Screen 172 |
| Description: | Various organ tumors with stage/grade and adjacent normal/non-neoplastic |
| Format: | FFPE |
| Category: | Human Tumor and Adjacent Normal |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 58 |
| Cores: | 60 |
| Slides Per Set: | 1 |
LS-SCA172 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Breast (Bst); Breast, Fibrofatty tissue (Bst); Cervix (Cvx); Colon (Col); Esophagus (Eso); Esophagus, Fibrous tissue and blood vessel (Eso); Kidney (Kid); Liver (Liv); Liver, Hepatocyte (Liv); Liver, Portal area fibrous tissue and blood vessel (Liv); Lung (Lng); Ovary (Ova); Rectum (Rec); Stomach (Sto);
LS-SCA172 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Grade | Tumor Stage |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 62 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | T3N1M0 | 2 | III |
| 1 | A2 | Human | M | 56 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | T3N0M0 | 2 | IIA |
| 1 | A3 | Human | F | 72 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 | IIA |
| 1 | A4 | Human | F | 55 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N2M0 | 3 | IIIB |
| 1 | A5 | Human | M | 56 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 2 | IIA |
| 1 | A6 | Human | M | 74 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 3 | IIIA |
| 1 | A7 | Human | M | 37 y | Colon (Col) | Adenocarcinoma | Malignant | T4N1M0 | 3 | IIIB |
| 1 | A8 | Human | F | 58 y | Colon (Col) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II |
| 1 | A9 | Human | M | 58 y | Colon (Col) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II |
| 1 | B1 | Human | M | 39 y | Esophagus (Eso) | Adjacent normal with reflux esophagitis | Diseased | |||
| 1 | B2 | Human | M | 53 y | Esophagus, Fibrous tissue and blood vessel (Eso) | Adjacent normal | Benign non-neoplastic | |||
| 1 | B3 | Human | F | 72 y | Esophagus (Eso) | Adjacent normal with hyperplasia | Diseased | |||
| 1 | B4 | Human | M | 54 y | Stomach (Sto) | Adjacent normal | Benign non-neoplastic | |||
| 1 | B5 | Human | M | 54 y | Stomach (Sto) | Adjacent normal | Benign non-neoplastic | |||
| 1 | B6 | Human | M | 40 y | Stomach (Sto) | Adjacent normal | Benign non-neoplastic | |||
| 1 | B7 | Human | M | 54 y | Colon (Col) | Adjacent normal | Benign non-neoplastic | |||
| 1 | B8 | Human | M | 61 y | Colon (Col) | Adjacent normal | Benign non-neoplastic | |||
| 1 | B9 | Human | M | 68 y | Colon (Col) | Adjacent normal | Benign non-neoplastic | |||
| 1 | C1 | Human | M | 55 y | Rectum (Rec) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II |
| 1 | C2 | Human | F | 58 y | Rectum (Rec) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I |
| 1 | C3 | Human | M | 48 y | Rectum (Rec) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II |
| 1 | C4 | Human | F | 32 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 1 | III |
| 1 | C5 | Human | M | 39 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 3 | III |
| 1 | C6 | Human | F | 55 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III |
| 1 | C7 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | I |
| 1 | C8 | Human | F | 59 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N2M0 | 3 | IIIA |
| 1 | C9 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | 2 | II |
| 1 | D1 | Human | F | 44 y | Rectum (Rec) | Adjacent normal | Benign non-neoplastic | |||
| 1 | D2 | Human | F | 58 y | Rectum (Rec) | Adjacent normal | Benign non-neoplastic | |||
| 1 | D3 | Human | F | 61 y | Rectum (Rec) | Adjacent normal | Benign non-neoplastic | |||
| 1 | D4 | Human | M | 35 y | Liver (Liv) | Adjacent normal with mild fatty degeneration | Diseased | |||
| 1 | D5 | Human | F | 66 y | Liver, Portal area fibrous tissue and blood vessel (Liv) | Adjacent normal with hyperplasia and inflammation | Inflammatory | |||
| 1 | D6 | Human | M | 31 y | Liver, Hepatocyte (Liv) | Adjacent normal with mild granular degeneration | Diseased | |||
| 1 | D7 | Human | M | 73 y | Lung (Lng) | Adjacent normal with congestion and hemorrhage | Diseased | |||
| 1 | D8 | Human | F | 68 y | Lung (Lng) | Adjacent normal | Benign non-neoplastic | |||
| 1 | D9 | Human | M | 65 y | Lung (Lng) | Adjacent normal | Benign non-neoplastic | |||
| 1 | E1 | Human | F | 71 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T2N0M0 | 1 | II |
| 1 | E2 | Human | M | 63 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 1 | I |
| 1 | E3 | Human | M | 54 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 1 | I |
| 1 | E4 | Human | F | 29 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA |
| 1 | E5 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 3 | I |
| 1 | E6 | Human | F | 60 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 3 | IIA |
| 1 | E7 | Human | F | 76 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T2N0M0 | 3 | II |
| 1 | E8 | Human | F | 47 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | II |
| 1 | E9 | Human | F | 42 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 | I |
| 1 | F1 | Human | F | 47 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F2 | Human | F | 61 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F3 | Human | M | 54 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F4 | Human | F | 43 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F5 | Human | F | 43 y | Breast, Fibrofatty tissue (Bst) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F6 | Human | F | 41 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F7 | Human | F | 57 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F8 | Human | F | 46 y | Breast, Fibrofatty tissue (Bst) | Adjacent normal | Benign non-neoplastic | |||
| 1 | F9 | Human | F | 40 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | |||
| 1 | G1 | Human | F | 56 y | Ovary (Ova) | Adenocarcinoma, Serous | Malignant | T3cN1M1 | 3 | IV |
| 1 | G2 | Human | F | 49 y | Ovary (Ova) | Adenocarcinoma, Serous | Malignant | T2N0M0 | 2 | II |
| 1 | G3 | Human | F | 39 y | Ovary (Ova) | Adenocarcinoma, Serous with necrosis | Malignant | T1aN0M0 | IA | |
| 1 | G4 | Human | F | 57 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | 3 | ||
| 1 | G5 | Human | F | 39 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | |||
| 1 | G6 | Human | F | 38 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic |